Press release
Key Trends Influencing the Growth of the Peptide Based Metabolic Disorders Therapeutics Market in 2025: Innovative Developments In Peptide-Based Therapeutics Biosimilars
Peptide Based Metabolic Disorders Therapeutics
What Is the Expected CAGR for the Peptide Based Metabolic Disorders Therapeutics Market Through 2025?
The market size for therapeutics centered around peptide-based metabolic disorders has visibly expanded in the last few years. It is projected to escalate from $29.89 billion in 2024 to $34.1 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.1%. The growth during the historic period can be linked to several factors, including a rise in metabolic disorders, advancements in peptide synthesis methods, increased healthcare spending, an aging population, growth in the biopharmaceutical sector, approval for new treatment methods by regulatory bodies, and heightening awareness of personalized medicine.
What's the Projected Size of the Global Peptide Based Metabolic Disorders Therapeutics Market by 2029?
The market for therapeutics focused on metabolic disorders using peptides is expected to experience a swift increase in size in the coming years, growing to "$57.13 billion by 2029 with a compound annual growth rate (CAGR) of 13.8%. This projected growth within the forecast period can be linked to several factors including the creation of innovative peptide analogs, increasing investments in metabolic disorder research and development, adoption of precision medicine methodologies, growth of emerging markets, collaboration and alliances in medication development, progress in delivery technologies, and an emphasis on therapies centered on the patient. The forecast period will likely see trends such as the use of artificial intelligence for drug discovery, growth in personalized treatments, application of CRISPR/Cas9 for genetic therapies, incorporation of wearable devices for patient tracking, development of oral peptide formulations, rise of digital therapeutics for managing diseases, and the enlarging presence of biobanking for personalized treatments.
View the full report here:
https://www.thebusinessresearchcompany.com/report/peptide-based-metabolic-disorders-therapeutics-global-market-report
Top Growth Drivers in the Peptide Based Metabolic Disorders Therapeutics Industry: What's Accelerating the Market?
Driven by the mounting incidence of obesity, the peptide-based metabolic disorders therapeutic market is poised to experience robust growth. Characterized by an unhealthy accumulation of body fat, obesity is a medical concern posing various health risks. Factors such as sedentary lifestyles, poor diet, genetic factors, and environmental factors promoting high-calorie food consumption and lack of physical activity contribute largely to the growth in obesity cases. Peptide-based metabolic disorders therapeutics are employed to manage obesity and related conditions. These peptide-based treatments work by regulating metabolic functions, enhancing insulin sensitivity, and controlling appetite, thus improving patient outcomes and mitigating long-term health issues associated with these chronic diseases. To illustrate, as per The British Diabetic Association, a charity of healthcare professionals and researchers based in the UK, in April 2024, around 4.4 million people in the UK were diagnosed with diabetes, with an estimated 1.2 million likely having undiagnosed type 2 diabetes. This figure marks an increase of 167,822 from the previous year, 2021-22. Consequently, the escalating prevalence of obesity is fueling the growth of the peptide-based metabolic disorder therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16764&type=smp
Which Emerging Trends Are Transforming the Peptide Based Metabolic Disorders Therapeutics Market in 2025?
Prominent companies in the peptide-based metabolic disorders therapeutics market are advancing in creating novel peptide-based solutions, including anti-diabetic biosimilars, to cater to unfulfilled medical needs and broaden patient care alternatives. Anti-diabetic biosimilars, based on peptides, are therapeutic drugs designed to simulate existing peptide therapies for diabetes, providing similar efficiency and safety standards to its traditional counterparts. However, they may reduce the expense of treatment due to competitive pricing tactics. For example, in January 2024, an Indian pharmaceutical company called Glenmark Pharmaceuticals Ltd. released Lirafit. This drug, a biosimilar to the well-known anti-diabetic medication Liraglutide, has been launched in India. It falls under the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) category. These drugs replicate the function of the naturally occurring GLP-1 hormone, key in controlling blood glucose levels. This biosimilar has undergone clinical testing and has shown efficiency in reducing glycemic parameters, endorsing weight loss, and augmenting cardiovascular safety. These factors are key in managing diabetes and associated complications like obesity and cardiovascular diseases.
What Are the Main Segments in the Peptide Based Metabolic Disorders Therapeutics Market?
The peptide based metabolic disorders therapeutics market covered in this report is segmented -
1) By Drug Type: Liraglutide, Exenatide, Other Drug Type
2) By Application: Lysosomal Storage Diseases, Diabetes, Obesity, Hypercholesterolemia, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Liraglutide: Brand: Saxenda, Brand: Victoza, Generic Liraglutide, Liraglutide For Type 2 Diabetes, Liraglutide For Obesity
2) By Exenatide: Brand: Byetta, Brand: Bydureon, Exenatide For Type 2 Diabetes, Extended-Release Exenatide, Generic Exenatide
3) By Other Drug Type: Semaglutide, Dulaglutide, Albiglutide, Lixisenatide, GLP-1 Receptor Agonists, Pramlintide, Other Peptide-Based Drugs For Metabolic Disorders
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16764&type=smp
Which Top Companies are Driving Growth in the Peptide Based Metabolic Disorders Therapeutics Market?
Major companies operating in the peptide based metabolic disorders therapeutics market are Pfizer Inc., Johnson And Johnson, Roche Holding AG, Merck And Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Eli Lilly Company, Amgen Inc., Gilead Sciences Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Jazz Pharmaceuticals plc, Ipsen S.A, BioMarin Pharmaceutical Inc., Amarin Corporation plc, PolyPeptide Group
Which Regions Will Dominate the Peptide Based Metabolic Disorders Therapeutics Market Through 2029?
North America was the largest region in the peptide based metabolic disorders therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide based metabolic disorders therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16764
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Trends Influencing the Growth of the Peptide Based Metabolic Disorders Therapeutics Market in 2025: Innovative Developments In Peptide-Based Therapeutics Biosimilars here
News-ID: 4183323 • Views: …
More Releases from The Business Research Company
Key Industry Players Strengthening Their Position In The Direct Coombs Test (DCT …
The Direct Coombs Test (DCT) antibody market is gaining significant traction as advancements in medical diagnostics and growing healthcare needs drive demand. With innovations enhancing testing accuracy and expanding applications across diverse medical fields, this market is set to experience substantial growth in the upcoming years. Let's explore the market's projected size, key players, trends shaping the industry, and how the market is segmented.
Direct Coombs Test (DCT) Antibody Market Size…
Global Trends Analysis: How The Dental Practice Analytics Dashboards Market Is R …
The dental practice analytics dashboards market is on track for significant expansion in the coming years, driven by the increasing use of data and technology in dental care management. As dental practices seek more efficient and patient-centered solutions, this market is set to grow rapidly, with new innovations and partnerships further enhancing its potential.
Projected Market Size and Growth for Dental Practice Analytics Dashboards
The market for dental practice analytics dashboards is…
Datacenters Market Structure, Emerging Trends, And Leading Player Insights
The datacenters market is on the verge of remarkable growth as digital transformation accelerates across multiple industries. Driven by cutting-edge technologies and changing business needs, this sector is set to expand rapidly in the coming years. Let's explore the current market size, the main companies involved, emerging trends, and the key segments shaping the future of datacenters globally.
Steady Growth Forecast for the Datacenters Market by 2029
The global datacenters market is…
Key Industry Players Strengthening Their Position In The Contract Food Service M …
The contract food service management sector is on track for notable expansion as consumer preferences and operational models evolve. Driven by rising health consciousness and technological advancements, this market is adapting to meet new demands while exploring innovative solutions. Let's delve into the current market size, key players, emerging trends, and major segments shaping the industry's future.
Projected Market Value and Growth Dynamics in the Contract Food Service Management Market
The contract…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
